Insufficient scRNA-seq data for expression of ADRA1D at single-cell level.
Insufficient scRNA-seq data for expression of ADRA1D at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 97% | 465.84 | 237 / 245 | 58% | 2.38 | 293 / 502 |
brain | 64% | 171.22 | 1686 / 2642 | 65% | 2.98 | 458 / 705 |
lung | 99% | 315.61 | 572 / 578 | 20% | 1.15 | 228 / 1155 |
uterus | 99% | 426.20 | 169 / 170 | 16% | 0.89 | 72 / 459 |
bladder | 100% | 325.76 | 21 / 21 | 8% | 0.30 | 39 / 504 |
thymus | 92% | 112.20 | 599 / 653 | 5% | 0.07 | 28 / 605 |
spleen | 95% | 189.74 | 228 / 241 | 0% | 0 | 0 / 0 |
adipose | 93% | 151.42 | 1115 / 1204 | 0% | 0 | 0 / 0 |
breast | 85% | 109.01 | 391 / 459 | 6% | 0.30 | 66 / 1118 |
blood vessel | 85% | 382.75 | 1130 / 1335 | 0% | 0 | 0 / 0 |
intestine | 69% | 154.97 | 668 / 966 | 13% | 0.42 | 68 / 527 |
esophagus | 57% | 76.96 | 820 / 1445 | 22% | 1.02 | 40 / 183 |
stomach | 49% | 194.62 | 177 / 359 | 27% | 1.56 | 78 / 286 |
adrenal gland | 52% | 43.70 | 133 / 258 | 18% | 1.70 | 41 / 230 |
ovary | 44% | 72.78 | 79 / 180 | 15% | 0.53 | 63 / 430 |
skin | 37% | 28.30 | 661 / 1809 | 6% | 0.15 | 26 / 472 |
kidney | 36% | 37.08 | 32 / 89 | 4% | 0.21 | 32 / 901 |
muscle | 33% | 22.18 | 267 / 803 | 0% | 0 | 0 / 0 |
liver | 6% | 5.73 | 14 / 226 | 15% | 0.84 | 61 / 406 |
pancreas | 16% | 9.93 | 51 / 328 | 5% | 0.08 | 9 / 178 |
heart | 10% | 7.87 | 82 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.08 | 3 / 45 |
peripheral blood | 0% | 0.05 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0045907 | Biological process | positive regulation of vasoconstriction |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0071880 | Biological process | adenylate cyclase-activating adrenergic receptor signaling pathway |
GO_0007267 | Biological process | cell-cell signaling |
GO_0150099 | Biological process | neuron-glial cell signaling |
GO_0005886 | Cellular component | plasma membrane |
GO_0004937 | Molecular function | alpha1-adrenergic receptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ADRA1D |
Protein name | Alpha-1D adrenergic receptor (Alpha-1D adrenoreceptor) Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a) |
Synonyms | hCG_1646223 ADRA1A |
Description | FUNCTION: This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium. FUNCTION: This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium. . |
Accessions | B0ZBE0 P25100 ENST00000379453.6 |